Cargando...
Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer
Ovarian cancer is the most lethal gynecological malignancy worldwide although exponential progress has been made in its treatment over the last decade. New agents and novel combination treatments are on the horizon. Among many new drugs, a series of PI3K/AKT/mTOR pathway (referred to as the PI3K pat...
Gardado en:
| Publicado en: | Cancer Treat Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7272282/ https://ncbi.nlm.nih.gov/pubmed/32311593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2020.102021 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|